BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
Rick Steves' Newest Guidebook Is A Fresh Perspective On Italy Spilling The Country's Secrets - 2Pick Your #1 Japanese Food
- 3Pick Your Number one sort of blossom
- 4Nick Reiner's defense attorney asks to be replaced, again delaying arraignment in connection with the stabbing deaths of his parents, Rob Reiner and Michele Singer Reiner
- 5Are multiverses real? An astrophysicist explains why it depends on how you define ‘real’
- From blowouts to big interiors, ‘Tuscan Mom’ style is Gen Z’s answer to beige burnout
- 20-year-old who threatened German train attack remanded in custody
- Brexit's Effect on New York's Ascent as a Main Monetary Center
- The 10 Most Progressive Logical Disclosures
- The Red Sea strategy: What does Israel stand to gain from recognizing Somaliland?
- 'Fertiliser costs mean I'm better off not planting'
- Spotify Wrapped and Apple Music Replay are here: Top songs, albums and artists of 2025
- 2 bright planets light up April evenings — here's where and when to look
- Scientists reveal earliest evidence for shifting of Earth’s crust
